Section
V
Table S16. Patient outcome data used in training set
Case Identifier |
Studya |
Relapseb |
No Relapsec |
inv16- #02 |
AML87 |
- |
234 |
inv16- #03 |
AML87 |
- |
4929 |
inv16- #05 |
AML91 |
- |
3598 |
inv16- #06 |
AML91 |
- |
1553 |
inv16- #08 |
AML97 |
- |
1136 |
inv16- #09 |
AML87 |
- |
4610 |
inv16- #10 |
AML97 |
496 |
- |
inv16- #11 |
AML97 |
- |
684 |
inv16- #12 |
AML97 |
- |
162 |
MLL- #01 |
AML87 |
252 |
- |
MLL- #03 |
AML91 |
0 |
- |
MLL- #04 |
AML91 |
378 |
- |
MLL- #05 |
AML91 |
- |
3445 |
MLL- #08 |
AML91 |
- |
2347 |
MLL- #09 |
AML91 |
710 |
- |
MLL- #10 |
AML91 |
- |
2293 |
MLL- #11 |
AML91 |
212 |
- |
MLL- #12 |
AML91 |
- |
1822 |
MLL- #14 |
AML97 |
- |
37 |
MLL- #16 |
AML97 |
- |
175 |
MLL- #17 |
AML97 |
- |
927 |
MLL- #18 |
AML97 |
471 |
- |
MLL- #19 |
AML97 |
- |
404 |
MLL- #23 |
AML97 |
- |
529 |
MLL-#21 |
AML87 |
- |
4549 |
Other- #02 |
AML87 |
386 |
- |
Other- #03 |
AML87 |
417 |
- |
Other- #05 |
AML87 |
458 |
- |
Other- #07 |
AML87 |
0 |
- |
Other- #08 |
AML87 |
267 |
- |
Other- #11 |
AML87 |
- |
4306 |
Other- #12 |
AML87 |
0 |
- |
Other- #13 |
AML91 |
1596 |
- |
Other- #15 |
AML91 |
1951 |
- |
Other- #16 |
AML91 |
- |
2688 |
Other- #18 |
AML97 |
- |
133 |
Other- #19 |
AML91 |
- |
2354 |
Other- #20 |
AML91 |
212 |
- |
Other- #21 |
AML91 |
268 |
- |
Other- #24 |
AML97 |
519 |
- |
Other- #25 |
AML97 |
- |
1927 |
Other- #26 |
AML97 |
- |
1790 |
Other- #27 |
AML97 |
0 |
- |
Other- #28 |
AML97 |
- |
272 |
Other- #31 |
AML97 |
- |
1235 |
Other- #33 |
AML87 |
0 |
- |
Other- #35 |
AML91 |
0 |
- |
Other- #36 |
AML97 |
- |
916 |
Other- #38 |
AML97 |
464 |
- |
Other- #40 |
AML97 |
115 |
- |
Other- #41 |
AML97 |
167 |
- |
Other- #43 |
AML97 |
- |
203 |
Other- #44 |
AML91 |
0 |
- |
Other- #45 |
AML91 |
146 |
- |
Other- #6 |
AML87 |
0 |
- |
Other-M7- #02 |
AML87 |
- |
4040 |
Other-M7- #04 |
AML97 |
- |
1967 |
Other-M7- #05 |
AML97 |
- |
1746 |
Other-M7- #06 |
AML97 |
179 |
- |
Other-M7- #08 |
AML91 |
0 |
- |
t(8;21)- #01 |
AML87 |
- |
4241 |
t(8;21)- #03 |
AML87 |
569 |
- |
t(8;21)- #04 |
AML87 |
0 |
- |
t(8;21)- #06 |
AML91 |
- |
3832 |
t(8;21)- #08 |
AML97 |
891 |
- |
t(8;21)- #09 |
AML97 |
415 |
- |
t(8;21)- #11 |
AML97 |
- |
1165 |
t(8;21)- #12 |
AML97 |
401 |
- |
a Treatment protocols: AML87, AML91, and AML97 are St.Jude Children’s Research Hospital institutional protocols.
b Shown is the number of days from diagnosis to relapse. “0” indicates that the patient never achieved a complete remission.
c Shown is the number of days from diagnosis to the last follow-up
|
